Control over Imidazoquinoline Immune Stimulation by pH-Degradable Poly(norbornene) Nanogels

Authors:

Abstract
Reactivation of the innate immune system by Toll-like-receptors (TLRs) agonists holds promise for anticancer immunotherapy. Severe side effects caused by unspecific and systemic activation of the immune system upon intravenous injection prevent the use of small molecule TLR-agonists for such purposes. However, covalent attachment of small molecule imidazoquinoline (IMDQ) TLR7/8 agonists to pH-degradable polymeric nanogels could be shown to drastically reduce systemic inflammation but retain activity to tumoral tissues and their draining lymph nodes. In here, we introduce the synthesis of poly(norbornene)-based, acid-degradable nanogels for covalent ligation of IMDQs. While the intact nanogels trigger sufficient TLR7/8 receptor stimulation, their degraded version of soluble, IMDQ-conjugated poly(norbornene) chains do hardly activate TLR7/8. This renders their clinical safety profile, as degradation products are obtained which would not only circumvent nanoparticle accumulation in the body but also provide non-active, polymer-bound IMDQ species. Their immunologically silent behavior guarantees both spatial and temporal control over immune activity and, thus, holds promise for improved clinical applications.
Funding Information
  • Deutsche Forschungsgemeinschaft (SFB 1066 / B04)

This publication has 44 references indexed in Scilit: